Poseida Therapeutics (PSTX)
(Delayed Data from NSDQ)
$2.76 USD
+0.06 (2.22%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $2.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (82 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.36 | 9.99 |
Current Quarter Estimate | -0.42 | 2.97 | 61.00 |
Year Ago Quarter Estimate | -0.35 | -4.89 | 54.84 |
Next Quarter Estimate | -0.45 | 4.11 | 63.00 |
Next Year Estimate | -1.97 | 25.30 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -14.60 | 18.10 | 15.67 |
Next Year | -25.48 | 9.30 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.33 |
Price/Book (MRQ) | 4.30 | 2.09 |
Price/Cash Flow (MRFY) | NA | 17.39 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -127.48% | -147.72% |
Return on Equity (TTM) | -121.01% | -60.38% |
Debt to Equity (MRQ) | 0.97 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.